Login

Financial Snapshot

Revenue
TTM
$1.398M
Gross Margin
TTM
8.37%
Net Income
TTM
-$2.896M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
240.23%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$4.060M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $25.692 Million

About

Elite Health Systems Inc. (OTCQB: EHSI) is a healthcare company building Medicare Advantage health plans, with an initial focus on Chronic Condition Special Needs Plans (C-SNPs) in California. The company generates revenue through employee leasing and consulting services provided to health clinic customers, a segment it entered via the acquisition of PSS in November 2025, which contributed $1,024,000 in revenue for the two months ended December 31, 2025. No revenue was recorded in 2024. The core strategic objective, as described in the 10-K filed April 15, 2026, is to apply for and build the regulatory and operational infrastructure required to operate Medicare Advantage plans. CEO and Chairman Dr. Prasad Jeereddi leads that effort. The company trades thinly on the OTCQB marketplace, has 163 holders of record as of April 8, 2026, and has declared no dividends on its common stock.

Revenue model
Transactional revenue from employee leasing and consulting services to health clinic customers, generated through subsidiary PSS following its November 2025 acquisition. Revenue for the two months ended December 31, 2025 was $1,024,000, with cost of revenue of $906,000. No revenue was recorded in the fiscal year ended December 31, 2024.
Products and services
Employee leasing and consulting services to health clinic customers (via PSS subsidiary, acquired November 2025). Planned products include Medicare Advantage health plans and Chronic Condition Special Needs Plans (C-SNPs) targeting Medicare beneficiaries with qualifying chronic conditions including congestive heart failure, diabetes mellitus, cardiovascular disorders, chronic lung disorders, chronic kidney disease, end-stage renal disease, dementia, stroke, and certain disabling neurological disorders.
Customers and end markets
Current customers are health clinics receiving leased employees and consulting services. Planned end market is Medicare beneficiaries, specifically those eligible for C-SNP plans based on CMS-approved chronic conditions. The broader Medicare Advantage market is growing, with C-SNP enrollment rising approximately 476,000 from 2024 to 2025, a roughly 71% increase, according to the Kaiser Family Foundation as cited in the 10-K filed April 15, 2026.
Value-chain role
Early-stage health plan operator and managed care organization, acting as the plan sponsor and administrator contracting with physicians, hospitals, and other providers. Also functions as a staffing and consulting intermediary to health clinics through its PSS subsidiary.
Geographic exposure
Initial Medicare Advantage plan development is focused on California, with stated intent to expand to other states in the future, per the 10-K filed April 15, 2026.

Source: SEC 10-K, filed 2026-04-15

Industry: Services-Specialty Outpatient Facilities, NEC Peers: Regional Health Properties Inc Rennova Health, Inc. HCA Healthcare Inc ETHEMA HEALTH Corp SUNLINK HEALTH SYSTEMS INC

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support